{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:05:35Z","timestamp":1775739935838,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:00:00Z","timestamp":1495843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00259-017-3722-4","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T22:45:47Z","timestamp":1495838747000},"page":"1575-1587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"44","author":[{"name":"On behalf of the Oncology Task Force of Spanish Society of Nuclear Medicine and Molecular Imaging","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Garc\u00eda Vicente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto C.","family":"Delgado-Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Amo-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"L\u00f3pez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Caresia Ar\u00f3ztegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Garc\u00eda Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Orcajo Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Garc\u00eda Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"de Arcocha Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Alv\u00e1rez Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,27]]},"reference":[{"key":"3722_CR1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3722_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.","journal-title":"Lancet Neurol"},{"key":"3722_CR3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000312657","volume":"78","author":"C Sioka","year":"2010","unstructured":"Sioka C, Fotopoulos A, Kyritsis AP. Paraneoplastic neurological syndromes and the role of PET imaging. Oncology. 2010;78:150\u20136.","journal-title":"Oncology"},{"key":"3722_CR4","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/brain\/124.11.2223","volume":"124","author":"JH Rees","year":"2001","unstructured":"Rees JH, Hain SF, Johnson MR, Hughes RA, Costa DC, Ell PJ, et al. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain. 2001;124:2223\u201331.","journal-title":"Brain"},{"key":"3722_CR5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0025-6196(11)60768-4","volume":"83","author":"RR Patel","year":"2008","unstructured":"Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008;83:917\u201322.","journal-title":"Mayo Clin Proc"},{"key":"3722_CR6","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","volume":"127","author":"S Younes-Mhenni","year":"2004","unstructured":"Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain. 2004;127:2331\u20138.","journal-title":"Brain"},{"key":"3722_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1531-8249(200007)48:1<105::AID-ANA16>3.0.CO;2-G","volume":"48","author":"JC Antoine","year":"2000","unstructured":"Antoine JC, Cinotti L, Tilikete C, Bouhour F, Camdessanche JP, Confavreux C, et al. 18 F-fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann Neurol. 2000a;48:105\u20138.","journal-title":"Ann Neurol"},{"key":"3722_CR8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/01.WNL.0000129983.06983.4E","volume":"63","author":"R Linke","year":"2004","unstructured":"Linke R, Schroeder M, Helmberger T, Voltz R. Antibody-positive paraneoplastic neurologic syndromes; value of CT and PET for tumour diagnosis. Neurology. 2004;63:282\u20136.","journal-title":"Neurology"},{"key":"3722_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011;18:19\u201323.","journal-title":"Eur J Neurol"},{"key":"3722_CR10","first-page":"236","volume":"34","author":"AM Garc\u00eda Vicente","year":"2015","unstructured":"Garc\u00eda Vicente AM, Vega Caicedo CH, Mond\u00e9jar Sol\u00eds R, de Ayala Fern\u00e1ndez JA, Garrido Robles JA, Pena Pardo FJ, et al. PET\/TC con 18F-FDG en la valoraci\u00f3n de pacientes con sospecha de s\u00edndrome paraneopl\u00e1sico neurol\u00f3gico. Rev Esp Med Nucl Imag Molec. 2015;34:236\u201343.","journal-title":"Rev Esp Med Nucl Imag Molec"},{"key":"3722_CR11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2010.10.009","volume":"232","author":"A Storstein","year":"2011","unstructured":"Storstein A, Monstad SE, Haugen M, Mazengia K, Veltman D, Lohndal E, et al. Onconeural antibodies: improved detection and clinical correlations. J Neuroimmunol. 2011;232:166\u201370.","journal-title":"J Neuroimmunol"},{"key":"3722_CR12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0404.2008.01089.x","volume":"119","author":"M Hadjivassiliou","year":"2009","unstructured":"Hadjivassiliou M, Alder SJ, Van Beek EJ, Hanney MB, Lorenz E, Rao DG, et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186\u201393.","journal-title":"Acta Neurol Scand"},{"key":"3722_CR13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"3722_CR14","doi-asserted-by":"crossref","unstructured":"Schwarzer G, Carpenter JR and R\u00fccker G. Meta-Analysis with R (Use-R!). Springer International. Publishing, Switzerland. 2015. http:\/\/www.springer.com\/gp\/book\/9783319214153 .","DOI":"10.1007\/978-3-319-21416-0_8"},{"key":"3722_CR15","first-page":"85","volume":"47","author":"U Berner","year":"2003","unstructured":"Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, D\u00f6bert N, et al. Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET. Q J Nucl Med. 2003;47:85\u20139.","journal-title":"Q J Nucl Med"},{"key":"3722_CR16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00330-009-1606-0","volume":"20","author":"P Bannas","year":"2010","unstructured":"Bannas P, Weber C, Derlin T, Lambert J, Leypoldt F, Adam G, et al. 18-F-FDG-PET\/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis. Eur Radiol. 2010;20:923\u201330.","journal-title":"Eur Radiol"},{"key":"3722_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneurol.2009.336","volume":"67","author":"A McKeon","year":"2010","unstructured":"McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, Boeve BF, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010;67:322\u20139.","journal-title":"Arch Neurol"},{"key":"3722_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RLU.0b013e3182393390","volume":"37","author":"A Matsuhisa","year":"2012","unstructured":"Matsuhisa A, Toriihara A, Kubota K, Makino T, Mizusawa H, Shibuya H. Utility of F-18 FDG PET\/CT in screening for paraneoplastic neurological syndromes. Clin Nucl Med. 2012;37:39\u201343.","journal-title":"Clin Nucl Med"},{"key":"3722_CR19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-013-2372-4","volume":"40","author":"N Schramm","year":"2013","unstructured":"Schramm N, Rominger A, Schmidt C, Morelli JN, Schmid-Tannwald C, et al. Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET\/CT and contrast-enhanced CT. Eur J Nucl Med Mol Imaging. 2013;40:1014\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3722_CR20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/MNM.0b013e3283550237","volume":"33","author":"S Vaidyanathan","year":"2012","unstructured":"Vaidyanathan S, Pennington C, Ng CY, Poon FW, Han S. 18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre. Nucl Med Commun. 2012;33:872\u201380.","journal-title":"Nucl Med Commun"},{"key":"3722_CR21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","volume":"123","author":"A Selva-O\u2019Callaghan","year":"2010","unstructured":"Selva-O\u2019Callaghan A, Grau JM, Gamez-Cenzano C, Vidaller-Palac\u00edn A, Mart\u00ednez-G\u00f3mez X, Trallero-Aragu\u00e1s E, et al. Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis. Am J Med. 2010;123:558\u201362.","journal-title":"Am J Med"},{"key":"3722_CR22","first-page":"641","volume":"35","author":"V Roux","year":"2011","unstructured":"Roux V, Olivier P, Taillandier L, Louis S, Sauvee M, Karcher G. Interest of 18FDG PET\/CT for etiological investigation of paraneoplastics syndromes. Medecine Nucleaire. 2011;35:641\u201351.","journal-title":"Medecine Nucleaire"},{"key":"3722_CR23","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s00259-015-3126-2","volume":"42","author":"SB Kristensen","year":"2015","unstructured":"Kristensen SB, Hess S, Petersen H, H\u00f8ilund-Carlsen PF. Clinical value of FDG-PET\/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients. Eur J Nucl Med Mol Imaging. 2015;42:2056\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3722_CR24","first-page":"17","volume":"35","author":"B Vatankulu","year":"2016","unstructured":"Vatankulu B, Yilmaz Aksoy S, Asa S, Sager S, Sayman HB, Halac M, et al. Accuracy of FDG-PET\/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Rev Esp Med Nucl Imagen Mol. 2016;35:17\u201321.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"3722_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrc1255","volume":"4","author":"ML Albert","year":"2004","unstructured":"Albert ML, Darnell RB. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer. 2004;4:36\u201344.","journal-title":"Nat Rev Cancer"},{"key":"3722_CR26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, et al. Paraneoplastic neurological syndrome Euronetwork. Management of paraneoplastic neurological syndromes: report of an EFNS task force. Eur J Neurol. 2006;13:682\u201390.","journal-title":"Eur J Neurol"},{"key":"3722_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-2004-861540","volume":"24","author":"L Bataller","year":"2004","unstructured":"Bataller L, Dalmau JO. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol. 2004;24:461\u201371.","journal-title":"Semin Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3722-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3722-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3722-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:05:23Z","timestamp":1602180323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3722-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,27]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3722-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,27]]}}}